all news

Our partners are building great companies. We love to share their stories.

Tue, 16 Jul 2024

Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline of Innovative Medicines for Cardiovascular Disea

Mon, 8 Jul 2024 PR Newswire

Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

Tue, 2 Jul 2024 Associated Press

From Call to Care: ESO Acquires Logis Solutions, Reinventing Emergency Response

Tue, 2 Jul 2024 Associated Press

Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive

Wed, 26 Jun 2024 Associated Press

TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases

Wed, 26 Jun 2024 Life Science Leader

Companies To Watch: Volastra Therapeutics

Wed, 26 Jun 2024 Washington latest

10 of the most exciting digital health startups of 2024, according to VCs

Tue, 25 Jun 2024 Associated Press

Sovato Announces Multiple Successful Remote Robotic-Assisted Procedures Over a 500-Mile Distance with the Use of the Sovato Platform

Tue, 25 Jun 2024 PR Newswire

QurAlis Expands its Industry-Leading Precision Medicine Approach in Splicing Targets Beyond Neurodegeneration Into Fragile X Syndrome (FXS)

Tue, 25 Jun 2024 Dewpoint Therapeutics

Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery

Mon, 24 Jun 2024 TechNews180

Vico Therapeutics Secures €65.8M in Series B Funding Led by Seroba and Kurma Partners

Mon, 24 Jun 2024 Dewpoint Therapeutics

Dewpoint Therapeutics Welcomes Dr. Lis Leiderman as Chief Financial and Corporate Development Officer

Fri, 21 Jun 2024 Neumora Therapeutics, Inc.

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation | Neumora Therapeutic

Thu, 20 Jun 2024

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Wed, 19 Jun 2024 PRWeb

Panalgo and OM1 Expand Partnership to Offer OM1's PremiOM Datasets in Panalgo's IHD Analytics Platform

Mon, 17 Jun 2024 Associated Press

Nomad Health Secures $22 Million; Justin Lambert Appointed CEO

Fri, 14 Jun 2024 Associated Press

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

Thu, 13 Jun 2024

OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence

Wed, 12 Jun 2024 KSQ Therapeutics

KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Ly

Wed, 12 Jun 2024 PR Newswire

Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates

Tue, 11 Jun 2024 GlobeNewswire

Faraday Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Iocyte AMI-3 Trial of FDY-5301

Tue, 11 Jun 2024 PR Newswire

QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors

Tue, 4 Jun 2024 Massachusetts Biotechnology Council

Member Spotlight: Q&A with KSQ Therapeutics

Tue, 4 Jun 2024 Associated Press

Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation

Tue, 4 Jun 2024 Food Business News

ByHeart expanding reach of infant formula products

Wed, 29 May 2024 PR Newswire

Quantcast Launches Innovative Advertising Platform, Inviting Agencies and Advertisers of All Sizes to the Open Web

Wed, 22 May 2024 Scholar Rock Holding Corp

Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity

Wed, 22 May 2024 GlobeNewswire

Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopause

Thu, 16 May 2024 PR Newswire

Proof and Socure partner to combat fraud and forgery in the $200 trillion exchanged through contracts, authorizations, and forms

Wed, 15 May 2024 PR Newswire

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)